Market Overview

Jounce Therapeutics, Inc. (JNCE)

12.00 +0.65 (5.73%)

Analyst Ratings

DateResearch FirmActionCurrentPT
12/04/20HC Wainwright & Co.AssumesBuy11.0
11/10/20Roth CapitalMaintainsBuy15.0
11/03/20Raymond JamesDowngradesMarket Perform
9/02/20HC Wainwright & Co.MaintainsBuy9.0
5/07/20H.C. WainwrightMaintainsBuy8.0
3/25/20Raymond JamesUpgradesStrong Buy11.0
3/02/20H.C. WainwrightReiteratesBuy10.0
11/14/18JP MorganDowngradesUnderweight
10/23/18Raymond JamesMaintainsOutperform12.0
8/10/18JP MorganMaintainsNeutral10.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter